Kiniksa Pharmaceuticals, Ltd. (KNSA)
NASDAQ: KNSA · IEX Real-Time Price · USD
21.23
+0.07 (0.33%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Kiniksa Pharmaceuticals Employees
Kiniksa Pharmaceuticals had 297 employees as of December 31, 2023. The number of employees increased by 77 or 35.00% compared to the previous year.
Employees
297
Change (1Y)
77
Growth (1Y)
35.00%
Revenue / Employee
$1,016,067
Profits / Employee
$29,125
Market Cap
1.51B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 297 | 77 | 35.00% |
Dec 31, 2022 | 220 | 5 | 2.33% |
Dec 31, 2021 | 215 | 47 | 27.98% |
Dec 31, 2020 | 168 | 31 | 22.63% |
Dec 31, 2019 | 137 | 26 | 23.42% |
Dec 31, 2018 | 111 | 64 | 136.17% |
Dec 31, 2017 | 47 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Brookdale Senior Living | 36,000 |
Teladoc Health | 5,600 |
Tilray Brands | 1,600 |
Schrödinger | 867 |
Alphatec Holdings | 839 |
InMode | 581 |
MannKind | 414 |
Avadel Pharmaceuticals | 154 |
KNSA News
- 5 days ago - Kiniksa Pharmaceuticals to Report Second Quarter 2024 Financial Results on July 23, 2024 - GlobeNewsWire
- 12 days ago - Kiniksa Pharmaceuticals Commences Enrollment in Abiprubart Phase 2b Clinical Trial in Sjögren's Disease - GlobeNewsWire
- 4 weeks ago - Kiniksa Pharmaceuticals Sponsors American Heart Association's Addressing Recurrent Pericarditis Initiative - GlobeNewsWire
- 6 weeks ago - Kiniksa Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Kiniksa Pharmaceuticals to Present at Bank of America Securities 2024 Health Care Conference - GlobeNewsWire
- 3 months ago - Kiniksa Pharmaceuticals Reports First Quarter 2024 Financial Results and Recent Portfolio Execution - GlobeNewsWire
- 3 months ago - Kiniksa Pharmaceuticals to Report First Quarter 2024 Financial Results on April 23, 2024 - GlobeNewsWire
- 3 months ago - Kiniksa Pharmaceuticals Announces Development Indication for Abiprubart - GlobeNewsWire